S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:SONM

Sonim Technologies (SONM) Stock Price, News & Analysis

$0.48
-0.02 (-4.00%)
(As of 04/19/2024 ET)
Today's Range
$0.48
$0.51
50-Day Range
$0.50
$0.71
52-Week Range
$0.47
$1.30
Volume
42,032 shs
Average Volume
89,631 shs
Market Capitalization
$20.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SONM stock logo

About Sonim Technologies Stock (NASDAQ:SONM)

Sonim Technologies, Inc. provides ruggedized mobile phones and accessories for task workers. The company offers ruggedized mobile phones, such as Sonim XP10, Sonim XP5plus, Sonim XP3plus based on the Android platform that are capable of attaching to public and private wireless networks; industrial-grade accessories, including remote speaker microphones, multi-bay charging accessories, and in-vehicle hands-free voice communications solutions; and cloud-based software and application services. It sells its mobile phones and accessories primarily to wireless carriers in the United States and Canada; and sells ruggedized phones, barcode scanners, and accessories through distribution channels in North America, South America, and Europe. The company serves transportation and logistics, construction, manufacturing, facilities management, energy and utility, and public sectors. The company was formerly known as NaviSpin.com, Inc. and changed its name to Sonim Technologies, Inc. in December 2001. Sonim Technologies, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

SONM Stock Price History

SONM Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Sonim Technologies Inc (SONM)
Sonim Technologies, Inc.
Sonim Set to Seize Market Opportunity Amidst Bullitt Exit
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Sonim Technologies Inc.
Sonim (SONM) Stock Moves -0.03%: What You Should Know
Sonim Technologies to Present at The Microcap Conference
Sonim Technologies Inc SONM
Sonim Appoints Mike Mulica as Board Chair
See More Headlines
Receive SONM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonim Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/19/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Telephone & telegraph apparatus
Sub-Industry
N/A
Current Symbol
NASDAQ:SONM
Fax
N/A
Employees
54
Year Founded
N/A

Profitability

Net Income
$-90,000.00
Pretax Margin
0.30%

Debt

Sales & Book Value

Annual Sales
$93.63 million
Cash Flow
$0.05 per share
Book Value
$0.52 per share

Miscellaneous

Free Float
20,614,000
Market Cap
$20.75 million
Optionable
Not Optionable
Beta
2.40
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Clayton Crolius (Age 62)
    Chief Financial Officer
    Comp: $384.91k
  • Mr. Charles Becher (Age 56)
    Chief Commercial Officer & GM of North America
    Comp: $417.14k
  • Stephanie Sogawa
    Legal Counsel
  • Mr. Simon Rayne
    Senior VP and GM of the UK, EMEA & APAC

SONM Stock Analysis - Frequently Asked Questions

How have SONM shares performed in 2024?

Sonim Technologies' stock was trading at $0.7349 at the beginning of 2024. Since then, SONM shares have decreased by 34.7% and is now trading at $0.4801.
View the best growth stocks for 2024 here
.

When is Sonim Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our SONM earnings forecast
.

How were Sonim Technologies' earnings last quarter?

Sonim Technologies, Inc. (NASDAQ:SONM) issued its quarterly earnings data on Wednesday, March, 27th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.04. The company earned $13.43 million during the quarter, compared to the consensus estimate of $27.57 million. Sonim Technologies had a negative trailing twelve-month return on equity of 0.41% and a negative net margin of 0.10%.

When did Sonim Technologies' stock split?

Sonim Technologies shares reverse split on Thursday, September 16th 2021. The 1-10 reverse split was announced on Thursday, September 16th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 16th 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Bob Plaschke's approval rating as Sonim Technologies' CEO?

51 employees have rated Sonim Technologies Chief Executive Officer Bob Plaschke on Glassdoor.com. Bob Plaschke has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Sonim Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sonim Technologies investors own include TherapeuticsMD (TXMD), Acasti Pharma (ACST), Outlook Therapeutics (OTLK), Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), electroCore (ECOR), Heat Biologics (HTBX), Matinas BioPharma (MTNB) and NIO (NIO).

When did Sonim Technologies IPO?

Sonim Technologies (SONM) raised $50 million in an initial public offering on Friday, May 10th 2019. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. Oppenheimer and Lake Street served as the underwriters for the IPO and National Securities Corporation was co-manager.

How do I buy shares of Sonim Technologies?

Shares of SONM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SONM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners